Cortical hypermetabolism in MCI subjects: a compensatory mechanism? (original) (raw)

• Kim J, Basak JM, Holtzman DM. The role of apolipoprotein E in Alzheimer’s disease. Neuron. 2009;63(3):287–303. doi:10.1016/j.neuron.2009.06.026.
  Article PubMed Central CAS PubMed Google Scholar
• Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, et al. Imaging brain amyloid in Alzheimer’s disease with Pittsburgh Compound-B. Ann Neurol. 2004;55(3):306–19. doi:10.1002/ana.20009.
  Article CAS PubMed Google Scholar
• Shin J, Lee SY, Kim SJ, Kim SH, Cho SJ, Kim YB. Voxel-based analysis of Alzheimer’s disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG. Neuroimage. 2010;52(2):488–96. doi:10.1016/j.neuroimage.2010.04.013.
  Article PubMed Google Scholar
• Klunk WE, Wang Y, Huang GF, Debnath ML, Holt DP, Shao L, et al. The binding of 2-(4′-methylaminophenyl)benzothiazole to postmortem brain homogenates is dominated by the amyloid component. J Neurosci. 2003;23(6):2086–92.
  CAS PubMed Google Scholar
• Jack Jr CR, Lowe VJ, Weigand SD, Wiste HJ, Senjem ML, Knopman DS, et al. Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer’s disease: implications for sequence of pathological events in Alzheimer’s disease. Brain J Neurol. 2009;132(Pt 5):1355–65. doi:10.1093/brain/awp062.
  Article Google Scholar
• Forsberg A, Engler H, Almkvist O, Blomquist G, Hagman G, Wall A, et al. PET imaging of amyloid deposition in patients with mild cognitive impairment. Neurobiol Aging. 2008;29(10):1456–65. doi:10.1016/j.neurobiolaging.2007.03.029.
  Article CAS PubMed Google Scholar
• Okello A, Koivunen J, Edison P, Archer HA, Turkheimer FE, Nagren K, et al. Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study. Neurology. 2009;73(10):754–60. doi:10.1212/WNL.0b013e3181b23564.
  Article PubMed Central CAS PubMed Google Scholar
• Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Green RC, et al. The Alzheimer’s Disease Neuroimaging Initiative: a review of papers published since its inception. Alzheimers Dement. 2013;9(5):e111–94. doi:10.1016/j.jalz.2013.05.1769.
  Article PubMed Central PubMed Google Scholar
• Villemagne VL, Pike KE, Chetelat G, Ellis KA, Mulligan RS, Bourgeat P, et al. Longitudinal assessment of Abeta and cognition in aging and Alzheimer disease. Ann Neurol. 2011;69(1):181–92. doi:10.1002/ana.22248.
  Article PubMed Central CAS PubMed Google Scholar
• Aizenstein HJ, Nebes RD, Saxton JA, Price JC, Mathis CA, Tsopelas ND, et al. Frequent amyloid deposition without significant cognitive impairment among the elderly. Arch Neurol. 2008;65(11):1509–17. doi:10.1001/archneur.65.11.1509.
  Article PubMed Central PubMed Google Scholar
• Mintun MA, Larossa GN, Sheline YI, Dence CS, Lee SY, Mach RH, et al. [11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease. Neurology. 2006;67(3):446–52.
  Article CAS PubMed Google Scholar
• Chetelat G, Villemagne VL, Villain N, Jones G, Ellis KA, Ames D, et al. Accelerated cortical atrophy in cognitively normal elderly with high beta-amyloid deposition. Neurology. 2012;78(7):477–84. doi:10.1212/WNL.0b013e318246d67a.
  Article CAS PubMed Google Scholar
• Rodrigue KM, Kennedy KM, Devous Sr MD, Rieck JR, Hebrank AC, Diaz-Arrastia R, et al. beta-Amyloid burden in healthy aging: regional distribution and cognitive consequences. Neurology. 2012;78(6):387–95. doi:10.1212/WNL.0b013e318245d295.
  Article PubMed Central CAS PubMed Google Scholar
• Prohovnik I, Perl DP, Davis KL, Libow L, Lesser G, Haroutunian V. Dissociation of neuropathology from severity of dementia in late-onset Alzheimer disease. Neurology. 2006;66(1):49–55.
  Article CAS PubMed Google Scholar
• Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, et al. Physical basis of cognitive alterations in Alzheimer’s disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol. 1991;30(4):572–80. doi:10.1002/ana.410300410.
  Article CAS PubMed Google Scholar
• Holmes C, Boche D, Wilkinson D, Yadegarfar G, Hopkins V, Bayer A, et al. Long-term effects of Abeta42 immunisation in Alzheimer’s disease: follow-up of a randomised, placebo-controlled phase I trial. Lancet. 2008;372(9634):216–23. doi:10.1016/S0140-6736(08)61075-2.
  Article CAS PubMed Google Scholar
• Benilova I, Karran E, De Strooper B. The toxic Abeta oligomer and Alzheimer’s disease: an emperor in need of clothes. Nat Neurosci. 2012;15(3):349–57. doi:10.1038/nn.3028.
  Article CAS PubMed Google Scholar
• Sokoloff L, Reivich M, Kennedy C, Des Rosiers MH, Patlak CS, Pettigrew KD, et al. The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem. 1977;28(5):897–916.
  Article CAS PubMed Google Scholar
• Mosconi L, Mistur R, Switalski R, Tsui WH, Glodzik L, Li Y, et al. FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer’s disease. Eur J Nucl Med Mol Imaging. 2009;36(5):811–22. doi:10.1007/s00259-008-1039-z.
  Article PubMed Central CAS PubMed Google Scholar
• Nordberg A, Rinne JO, Kadir A, Langstrom B. The use of PET in Alzheimer disease. Nat Rev Neurol. 2010;6(2):78–87. doi:10.1038/nrneurol.2009.217.
  Article CAS PubMed Google Scholar
• Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer’s disease. Ann Neurol. 1997;42(1):85–94. doi:10.1002/ana.410420114.
  Article CAS PubMed Google Scholar
• Mosconi L, Tsui WH, De Santi S, Li J, Rusinek H, Convit A, et al. Reduced hippocampal metabolism in MCI and AD: automated FDG-PET image analysis. Neurology. 2005;64(11):1860–7.
  Article CAS PubMed Google Scholar
• Mosconi L, De Santi S, Li Y, Li J, Zhan J, Tsui WH, et al. Visual rating of medial temporal lobe metabolism in mild cognitive impairment and Alzheimer’s disease using FDG-PET. Eur J Nucl Med Mol Imaging. 2006;33(2):210–21.
  Article PubMed Google Scholar
• Anchisi D, Borroni B, Franceschi M, Kerrouche N, Kalbe E, Beuthien-Beumann B, et al. Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease. Arch Neurol. 2005;62(11):1728–33. doi:10.1001/archneur.62.11.1728.
  Article PubMed Google Scholar
• Stern Y. Cognitive reserve and Alzheimer disease. Alzheimer Dis Assoc Disord. 2006;20(2):112–7. doi:10.1097/01.wad.0000213815.20177.19.
  Article PubMed Google Scholar
• Sattler C, Toro P, Schonknecht P, Schroder J. Cognitive activity, education and socioeconomic status as preventive factors for mild cognitive impairment and Alzheimer’s disease. Psychiatry Res. 2012;196(1):90–5. doi:10.1016/j.psychres.2011.11.012.
  Article PubMed Google Scholar
• Okello A, Edison P, Archer HA, Turkheimer FE, Kennedy J, Bullock R, et al. Microglial activation and amyloid deposition in mild cognitive impairment: a PET study. Neurology. 2009;72(1):56–62. doi:10.1212/01.wnl.0000338622.27876.0d.
  Article PubMed Central CAS PubMed Google Scholar
• Edison P, Archer HA, Hinz R, Hammers A, Pavese N, Tai YF, et al. Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study. Neurology. 2007;68(7):501–8. doi:10.1212/01.wnl.0000244749.20056.d4.
  Article CAS PubMed Google Scholar
• McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology. 1984;34(7):939–44.
  Article CAS PubMed Google Scholar
• Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, et al. Current concepts in mild cognitive impairment. Arch Neurol. 2001;58(12):1985–92.
  Article CAS PubMed Google Scholar
• Ewers M, Insel P, Jagust WJ, Shaw L, Trojanowski JQ, Aisen P, et al. CSF biomarker and PIB-PET-derived beta-amyloid signature predicts metabolic, gray matter, and cognitive changes in nondemented subjects. Cereb Cortex. 2012;22(9):1993–2004. doi:10.1093/cercor/bhr271.
  Article PubMed Central PubMed Google Scholar
• Jagust WJ, Landau SM, Shaw LM, Trojanowski JQ, Koeppe RA, Reiman EM, et al. Relationships between biomarkers in aging and dementia. Neurology. 2009;73(15):1193–9. doi:10.1212/Wnl.0b013e3181bc010c.
  Article PubMed Central CAS PubMed Google Scholar
• Busche MA, Chen X, Henning HA, Reichwald J, Staufenbiel M, Sakmann B, et al. Critical role of soluble amyloid-beta for early hippocampal hyperactivity in a mouse model of Alzheimer’s disease. Proc Natl Acad Sci U S A. 2012;109(22):8740–5. doi:10.1073/pnas.1206171109.
  Article PubMed Central CAS PubMed Google Scholar
• Balducci C, Beeg M, Stravalaci M, Bastone A, Sclip A, Biasini E, et al. Synthetic amyloid-beta oligomers impair long-term memory independently of cellular prion protein. Proc Natl Acad Sci U S A. 2010;107(5):2295–300. doi:10.1073/pnas.0911829107.
  Article PubMed Central CAS PubMed Google Scholar
• Lesne S, Kotilinek L, Ashe KH. Plaque-bearing mice with reduced levels of oligomeric amyloid-beta assemblies have intact memory function. Neuroscience. 2008;151(3):745–9. doi:10.1016/j.neuroscience.2007.10.054.
  Article PubMed Central CAS PubMed Google Scholar
• Cleary JP, Walsh DM, Hofmeister JJ, Shankar GM, Kuskowski MA, Selkoe DJ, et al. Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat Neurosci. 2005;8(1):79–84. doi:10.1038/nn1372.
  Article CAS PubMed Google Scholar
• Jana A, Pahan K. Fibrillar amyloid-beta-activated human astroglia kill primary human neurons via neutral sphingomyelinase: implications for Alzheimer’s disease. J Neurosci. 2010;30(38):12676–89. doi:10.1523/JNEUROSCI.1243-10.2010.
  Article PubMed Central CAS PubMed Google Scholar
• Stern Y. Cognitive reserve in ageing and Alzheimer’s disease. Lancet Neurol. 2012;11(11):1006–12. doi:10.1016/S1474-4422(12)70191-6.
  Article PubMed Central PubMed Google Scholar
• Jagust WJ, Mormino EC. Lifespan brain activity, beta-amyloid, and Alzheimer’s disease. Trends Cogn Sci. 2011;15(11):520–6. doi:10.1016/j.tics.2011.09.004.
  Article PubMed Central PubMed Google Scholar
• Ossenkoppele R, Madison C, Oh H, Wirth M, van Berckel BN, Jagust WJ. Is verbal episodic memory in elderly with amyloid deposits preserved through altered neuronal function? Cereb Cortex. 2014;24(8):2210–8. doi:10.1093/cercor/bht076.
  Article PubMed Google Scholar
• Morbelli S, Perneczky R, Drzezga A, Frisoni GB, Caroli A, van Berckel BN, et al. Metabolic networks underlying cognitive reserve in prodromal Alzheimer disease: a European Alzheimer disease consortium project. J Nucl Med. 2013;54(6):894–902. doi:10.2967/jnumed.112.113928.
  Article CAS PubMed Google Scholar
• Cohen AD, Price JC, Weissfeld LA, James J, Rosario BL, Bi W, et al. Basal cerebral metabolism may modulate the cognitive effects of Abeta in mild cognitive impairment: an example of brain reserve. J Neurosci. 2009;29(47):14770–8. doi:10.1523/JNEUROSCI.3669-09.2009.
  Article PubMed Central CAS PubMed Google Scholar
• Borghammer P, Cumming P, Aanerud J, Gjedde A. Artefactual subcortical hyperperfusion in PET studies normalized to global mean: lessons from Parkinson’s disease. Neuroimage. 2009;45(2):249–57. doi:10.1016/j.neuroimage.2008.07.042.
  Article PubMed Google Scholar
• Borghammer P, Chakravarty M, Jonsdottir KY, Sato N, Matsuda H, Ito K, et al. Cortical hypometabolism and hypoperfusion in Parkinson’s disease is extensive: probably even at early disease stages. Brain Struct Funct. 2010;214(4):303–17. doi:10.1007/s00429-010-0246-0.
  Article PubMed Google Scholar
• Jack Jr CR, Knopman DS, Jagust WJ, Petersen RC, Weiner MW, Aisen PS, et al. Tracking pathophysiological processes in Alzheimer’s disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 2013;12(2):207–16. doi:10.1016/S1474-4422(12)70291-0.
  Article PubMed Central CAS PubMed Google Scholar
• Knight EM, Verkhratsky A, Luckman SM, Allan SM, Lawrence CB. Hypermetabolism in a triple-transgenic mouse model of Alzheimer’s disease. Neurobiol Aging. 2012;33(1):187–93. doi:10.1016/j.neurobiolaging.2010.02.003.
  Article CAS PubMed Google Scholar
• Busche MA, Eichhoff G, Adelsberger H, Abramowski D, Wiederhold KH, Haass C, et al. Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer’s disease. Science. 2008;321(5896):1686–9. doi:10.1126/science.1162844.
  Article CAS PubMed Google Scholar
• Calero MD, Navarro E. Relationship between plasticity, mild cognitive impairment and cognitive decline. Arch Clin Neuropsychol. 2004;19(5):653–60.
  Article PubMed Google Scholar
• Mesulam MM. A plasticity-based theory of the pathogenesis of Alzheimer’s disease. Ann N Y Acad Sci. 2000;924:42–52.
  Article CAS PubMed Google Scholar
• Kantarci K, Senjem ML, Lowe VJ, Wiste HJ, Weigand SD, Kemp BJ, et al. Effects of age on the glucose metabolic changes in mild cognitive impairment. AJNR Am J Neuroradiol. 2010;31(7):1247–53. doi:10.3174/ajnr.A2070.
  Article PubMed Central PubMed Google Scholar
• Iacono D, Resnick SM, O’Brien R, Zonderman AB, An Y, Pletnikova O, et al. Mild cognitive impairment and asymptomatic Alzheimer disease subjects: equivalent beta-amyloid and tau loads with divergent cognitive outcomes. J Neuropathol Exp Neurol. 2014;73(4):295–304. doi:10.1097/NEN.0000000000000052.
  Article PubMed Central CAS PubMed Google Scholar
• Bell KF, Bennett DA, Cuello AC. Paradoxical upregulation of glutamatergic presynaptic boutons during mild cognitive impairment. J Neurosci. 2007;27(40):10810–7. doi:10.1523/JNEUROSCI.3269-07.2007.
  Article CAS PubMed Google Scholar
• Riudavets MA, Iacono D, Resnick SM, O’Brien R, Zonderman AB, Martin LJ, et al. Resistance to Alzheimer’s pathology is associated with nuclear hypertrophy in neurons. Neurobiol Aging. 2007;28(10):1484–92. doi:10.1016/j.neurobiolaging.2007.05.005.
  Article PubMed Central CAS PubMed Google Scholar
• Sultana R, Butterfield DA. Regional expression of key cell cycle proteins in brain from subjects with amnestic mild cognitive impairment. Neurochem Res. 2007;32(4–5):655–62. doi:10.1007/s11064-006-9123-x.
  Article CAS PubMed Google Scholar
• Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82(4):239–59.
  Article CAS PubMed Google Scholar
• Dickerson BC, Salat DH, Greve DN, Chua EF, Rand-Giovannetti E, Rentz DM, et al. Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD. Neurology. 2005;65(3):404–11.
  Article CAS PubMed Google Scholar
• O’Brien JL, O’Keefe KM, LaViolette PS, DeLuca AN, Blacker D, Dickerson BC, et al. Longitudinal fMRI in elderly reveals loss of hippocampal activation with clinical decline. Neurology. 2010;74(24):1969–76. doi:10.1212/WNL.0b013e3181e3966e.
  Article PubMed Central PubMed Google Scholar
• Andres P, Parmentier FB, Escera C. The effect of age on involuntary capture of attention by irrelevant sounds: a test of the frontal hypothesis of aging. Neuropsychologia. 2006;44(12):2564–8. doi:10.1016/j.neuropsychologia.2006.05.005.
  Article PubMed Google Scholar
• Sperling RA, Laviolette PS, O’Keefe K, O’Brien J, Rentz DM, Pihlajamaki M, et al. Amyloid deposition is associated with impaired default network function in older persons without dementia. Neuron. 2009;63(2):178–88. doi:10.1016/j.neuron.2009.07.003.
  Article PubMed Central CAS PubMed Google Scholar
• Bakker A, Krauss GL, Albert MS, Speck CL, Jones LR, Stark CE, et al. Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment. Neuron. 2012;74(3):467–74. doi:10.1016/j.neuron.2012.03.023.
  Article PubMed Central CAS PubMed Google Scholar
• Risberg J, Passant U, Warkentin S, Gustafson L. Regional cerebral blood flow in frontal lobe dementia of non-Alzheimer type. Dementia. 1993;4(3-4):186–7.
  CAS PubMed Google Scholar
• Rohrer JD, Warren JD, Omar R, Mead S, Beck J, Revesz T, et al. Parietal lobe deficits in frontotemporal lobar degeneration caused by a mutation in the progranulin gene. Arch Neurol. 2008;65(4):506–13. doi:10.1001/archneur.65.4.506.
  Article PubMed Central PubMed Google Scholar